A High-Throughput Method for Characterizing Novel Chimeric Antigen Receptors in Jurkat Cells
Open Access
- 30 January 2020
- journal article
- research article
- Published by Elsevier BV in Molecular Therapy - Methods & Clinical Development
- Vol. 16, 238-254
- https://doi.org/10.1016/j.omtm.2020.01.012
Abstract
No abstract availableFunding Information
- National Research Council Canada
This publication has 38 references indexed in Scilit:
- Engineering T Cell Function Using Chimeric Antigen Receptors Identified Using a DNA Library ApproachPLOS ONE, 2013
- An Efficient Low Cost Method for Gene Transfer to T LymphocytesPLOS ONE, 2013
- Eradication of B-lineage cells and regression of lymphoma in a patient treated with autologous T cells genetically engineered to recognize CD19Blood, 2010
- PCR-based detection and eradication of mycoplasmal infections from various mammalian cell lines: a local experienceCytotechnology, 2009
- Construction and Preclinical Evaluation of an Anti-CD19 Chimeric Antigen ReceptorJournal of Immunotherapy, 2009
- Control of large, established tumor xenografts with genetically retargeted human T cells containing CD28 and CD137 domainsProceedings of the National Academy of Sciences of the United States of America, 2009
- A One Pot, One Step, Precision Cloning Method with High Throughput CapabilityPLOS ONE, 2008
- Inducible Packaging Cells for Large-scale Production of Lentiviral Vectors in Serum-free Suspension CultureMolecular Therapy, 2008
- Interactions of EGFR and caveolin-1 in human glioblastoma cells: evidence that tyrosine phosphorylation regulates EGFR association with caveolaeOncogene, 2004
- Structure of the extracellular region of HER2 alone and in complex with the Herceptin FabNature, 2003